Description

3-Methyl-8-(Piperidin-1-Yl)-7-(2-(Piperidin-1-Yl)Ethyl)-3,7-Dihydro-1H-Purine-2,6-Dione is a high-purity, synthetically derived xanthine derivative with a complex, multi-cyclic structure. This compound is of significant interest in advanced pharmaceutical research and development, particularly as a key intermediate or active pharmaceutical ingredient (API) precursor for novel therapeutics. It is primarily utilized by research institutions, pharmaceutical manufacturers, and fine chemical suppliers engaged in the synthesis of specialized drug candidates targeting neurological and cardiovascular pathways.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel adenosine receptor antagonists or phosphodiesterase (PDE) inhibitors.
• Biochemical Research: Used as a reference standard or tool compound in pharmacological studies to investigate purinergic signaling pathways.
• Drug Discovery: Acts as a core scaffold for medicinal chemistry programs aimed at developing new treatments for conditions like asthma, inflammation, or Parkinson's disease.
• Fine Chemical Synthesis: Employed in multi-step organic synthesis to create more complex, target-specific molecules for clinical evaluation.
• Reference Material: Supplied to analytical laboratories for method development and quality control testing of related pharmaceutical products.

Basic Information

Product Name	3-Methyl-8-(Piperidin-1-Yl)-7-(2-(Piperidin-1-Yl)Ethyl)-3,7-Dihydro-1H-Purine-2,6-Dione
CAS No.	330818-23-0
Molecular Formula	C18H28N6O2
Molecular Weight	360.46 g/mol
Synonyms	3-Methyl-8-(1-piperidinyl)-7-[2-(1-piperidinyl)ethyl]-3,7-dihydro-1H-purine-2,6-dione; 1H-Purine-2,6-dione, 3,7-dihydro-3-methyl-8-(1-piperidinyl)-7-[2-(1-piperidinyl)ethyl]-; SCH-58261; SCH 58261; 8-(Piperidin-1-yl)-7-[2-(piperidin-1-yl)ethyl]-3-methyl-3,7-dihydro-1H-purine-2,6-dione
EINECS	Contact for details

Quality Control

Our production of 3-Methyl-8-(Piperidin-1-Yl)-7-(2-(Piperidin-1-Yl)Ethyl)-3,7-Dihydro-1H-Purine-2,6-Dione adheres to stringent quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the exacting standards required for pharmaceutical research. A detailed Certificate of Analysis (COA) documenting purity, impurities, and physical characteristics is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound is moisture-sensitive; keep the container tightly sealed in a dry environment to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.